Multimodality Risk Adapted Tx Including Induction Chemo for SCCHN Amenable to Transoral Surgery
UNC Lineberger Comprehensive Cancer Center
UNC Lineberger Comprehensive Cancer Center
Abramson Cancer Center at Penn Medicine
NRG Oncology
Royal Marsden NHS Foundation Trust
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
Dana-Farber Cancer Institute
Case Comprehensive Cancer Center
Grupo Español de Tratamiento de Tumores de Cabeza y Cuello
University of Pittsburgh
University of Oxford
Shanghai Jiao Tong University School of Medicine
The Netherlands Cancer Institute
H. Lee Moffitt Cancer Center and Research Institute
M.D. Anderson Cancer Center
Boston Scientific Corporation
State University of New York - Upstate Medical University
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
M.D. Anderson Cancer Center
Blokhin's Russian Cancer Research Center
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
M.D. Anderson Cancer Center
Stanford University
Chang Gung Memorial Hospital
HealthCare Global Enterprise Ltd.
Swedish Orphan Biovitrum
Biotech Pharmaceutical Co., Ltd.
M.D. Anderson Cancer Center
AstraZeneca
National Taiwan University Hospital
Sanofi
AstraZeneca
Hamamatsu University
National Institutes of Health Clinical Center (CC)